Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorDINIZ, Breno S.
dc.contributor.authorNUNES, Paula V.
dc.contributor.authorMACHADO-VIEIRA, Rodrigo
dc.contributor.authorFORLENZA, Orestes V.
dc.date.accessioned2017-11-27T16:34:25Z
dc.date.available2017-11-27T16:34:25Z
dc.date.issued2011
dc.description.abstractPurpose of review This work aims to review the most recent developments in the treatment of mood disorders (major depression and bipolar disorder) in the elderly. Recent findings In the last years, few new pharmacological interventions for mood disorders have been developed. Recent studies seek to provide alternative treatment strategies to achieve higher remission rates, including the association of antidepressants, mood stabilizers and psychotherapy and the treatment of specific clusters of symptoms, such as the adjunctive treatment of cognitive impairment with cholinesterase inhibitors. Also, recent studies have been assessing the potential of pharmacogenetic information in the prediction of treatment outcomes. Summary These factors altogether are expected to help the development of personalized treatment strategies that may improve outcomes with fewer adverse effects.
dc.description.indexMEDLINE
dc.description.sponsorshipFAPESP [02/13633-7, 2009/52825-8]
dc.description.sponsorshipAssociacao Beneficiente Alzira Denise Hertzog da Silva (ABADHS)
dc.description.sponsorshipCNPq [554535/2005-0]
dc.description.sponsorshipAlzheimer's Association [NIRG-08-90688]
dc.identifier.citationCURRENT OPINION IN PSYCHIATRY, v.24, n.6, p.473-477, 2011
dc.identifier.doi10.1097/YCO.0b013e32834bb9bd
dc.identifier.issn0951-7367
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/23376
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofCurrent Opinion in Psychiatry
dc.rightsrestrictedAccess
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINS
dc.subjectantidepressants
dc.subjectbipolar disorder
dc.subjectmajor depression
dc.subjectmood disorders
dc.subjectmood stabilizers
dc.subjecttreatment
dc.subject.otherlate-life depression
dc.subject.otherrandomized controlled-trial
dc.subject.otheranxiety treatments canmat
dc.subject.otherdouble-blind
dc.subject.otherbipolar disorder
dc.subject.otherolder-adults
dc.subject.othermaintenance treatment
dc.subject.othercognitive impairment
dc.subject.otherresidual symptoms
dc.subject.othercanadian network
dc.subject.wosPsychiatry
dc.titleCurrent pharmacological approaches and perspectives in the treatment of geriatric mood disorders
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus7
hcfmusp.contributor.author-fmusphcBRENO SATLER DE OLIVEIRA DINIZ
hcfmusp.contributor.author-fmusphcPAULA VILLELA NUNES
hcfmusp.contributor.author-fmusphcRODRIGO MACHADO VIEIRA
hcfmusp.contributor.author-fmusphcORESTES VICENTE FORLENZA
hcfmusp.description.beginpage473
hcfmusp.description.endpage477
hcfmusp.description.issue6
hcfmusp.description.volume24
hcfmusp.origemWOS
hcfmusp.origem.pubmed21918446
hcfmusp.origem.scopus2-s2.0-80053385284
hcfmusp.origem.wosWOS:000295321400003
hcfmusp.publisher.cityPHILADELPHIA
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceBaldwin R, 2004, PSYCHOL MED, V34, P125, DOI 10.1017/S0033291703008870
hcfmusp.relation.referenceCosta E, 2007, AM J GERIAT PSYCHIAT, V15, P17, DOI 10.1097/01.JGP.0000230659.72417.a0
hcfmusp.relation.referenceKessing LV, 2010, BIPOLAR DISORD, V12, P87, DOI 10.1111/j.1399-5618.2009.00788.x
hcfmusp.relation.referenceAzar AR, 2011, INT J GERIATR PSYCH, V26, P48, DOI 10.1002/gps.2485
hcfmusp.relation.referenceDombrovski AY, 2007, J AFFECT DISORDERS, V103, P77, DOI 10.1016/j.jad.2007.01.020
hcfmusp.relation.referenceCulang ME, 2009, AM J GERIAT PSYCHIAT, V17, P881, DOI 10.1097/JGP.0b013e3181b4bf4a
hcfmusp.relation.referenceBell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424
hcfmusp.relation.referenceAndreescu C, 2011, PSYCHIAT CLIN N AM, V34, P335, DOI 10.1016/j.psc.2011.02.005
hcfmusp.relation.referenceCharney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664
hcfmusp.relation.referenceAlexopoulos GS, 2010, J AFFECT DISORDERS, V125, P262, DOI 10.1016/j.jad.2010.02.115
hcfmusp.relation.referenceGrabovich A, 2010, AM J GERIAT PSYCHIAT, V18, P227, DOI 10.1097/JGP.0b013e3181cb87d6
hcfmusp.relation.referenceButters MA, 2004, ARCH GEN PSYCHIAT, V61, P587, DOI 10.1001/archpsyc.61.6.587
hcfmusp.relation.referenceRoose SP, 2005, J CLIN PSYCHOPHARM, V25, pS1, DOI 10.1097/01.jcp.0000162807.84570.6b
hcfmusp.relation.referenceYoung RC, 2010, BIPOLAR DISORD, V12, P56, DOI 10.1111/j.1399-5618.2009.00779.x
hcfmusp.relation.referencePelton GH, 2008, INT J GERIATR PSYCH, V23, P670, DOI 10.1002/gps.1958
hcfmusp.relation.referenceLam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041
hcfmusp.relation.referenceReynolds CF, 2011, ARCH GEN PSYCHIAT, V68, P51, DOI 10.1001/archgenpsychiatry.2010.184
hcfmusp.relation.referenceLavsa SM, 2010, AM J HEALTH-SYST PH, V67, P1274, DOI 10.2146/ajhp090611
hcfmusp.relation.referenceYatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x
hcfmusp.relation.referenceAlexopoulos GS, 2009, J AFFECT DISORDERS, V119, P132, DOI 10.1016/j.jad.2009.03.004
hcfmusp.relation.referenceMoller HJ, 2010, PHARMACOPSYCHIATRY, V43, P210, DOI 10.1055/s-0030-1254152
hcfmusp.relation.referenceBlay SL, 2007, AM J GERIAT PSYCHIAT, V15, P790, DOI 10.1097/JGP.0b013e3180654179
hcfmusp.relation.referencePinquart M, 2006, AM J PSYCHIAT, V163, P1493, DOI 10.1176/appi.ajp.163.9.1493
hcfmusp.relation.referenceMottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
hcfmusp.relation.referenceShores MM, 2009, J CLIN PSYCHIAT, V70, P1009
hcfmusp.relation.referenceMezuk B, 2010, AM J GERIAT PSYCHIAT, V18, P245, DOI 10.1097/JGP.0b013e3181bf9ebd
hcfmusp.relation.referenceMeyers BS, 2009, ARCH GEN PSYCHIAT, V66, P838, DOI 10.1001/archgenpsychiatry.2009.79
hcfmusp.relation.referenceForlenza OV, 2011, BRIT J PSYCHIAT, V198, P351, DOI 10.1192/bjp.bp.110.080044
hcfmusp.relation.referenceReynolds CF, 2010, INT J GERIATR PSYCH, V25, P1134, DOI 10.1002/gps.2443
hcfmusp.relation.referenceConradi HJ, 2011, PSYCHOL MED, V41, P1165, DOI 10.1017/S0033291710001911
hcfmusp.relation.referenceLavretsky H, 2005, J CLIN PSYCHIAT, V66, P964
hcfmusp.relation.referenceButters MA, 2000, AM J PSYCHIAT, V157, P1949, DOI 10.1176/appi.ajp.157.12.1949
hcfmusp.relation.referenceSneed JR, 2010, AM J GERIAT PSYCHIAT, V18, P128, DOI 10.1097/JGP.0b013e3181c796d2
hcfmusp.relation.referenceMcIntyre RS, 2010, J AFFECT DISORDERS, V126, P366, DOI 10.1016/j.jad.2010.04.012
hcfmusp.relation.referenceSchouws SNTM, 2010, J AFFECT DISORDERS, V125, P330, DOI 10.1016/j.jad.2009.12.004
hcfmusp.relation.referenceAziz Rehan, 2006, Am J Geriatr Pharmacother, V4, P347, DOI 10.1016/j.amjopharm.2006.12.007
hcfmusp.relation.referenceBalanza-Martinez V, 2010, EUR J PHARMACOL, V626, P87, DOI 10.1016/j.ejphar.2009.10.018
hcfmusp.relation.referenceCopeland John R M, 2004, World Psychiatry, V3, P45
hcfmusp.relation.referenceDrago Antonio, 2009, Human Genomics, V3, P257
hcfmusp.relation.referenceForlenza OV, 2001, INT PSYCHOGERIATR, V13, P75, DOI 10.1017/S1041610201007475
hcfmusp.relation.referenceIhara K, 1998, Environ Health Prev Med, V3, P44, DOI 10.1007/BF02931238
hcfmusp.relation.referenceJarman CN, 2010, J ALTERN COMPLEM MED, V16, P251, DOI 10.1089/acm.2009.0325
hcfmusp.relation.referenceRondanelli M, 2010, J AM COLL NUTR, V29, P55
hcfmusp.relation.referenceSajatovic M, 2011, PSYCHIAT CLIN N AM, V34, P319, DOI 10.1016/j.psc.2011.02.007
hcfmusp.relation.referenceSousa R. T., 2011, NEUROSCI LETT, V494, P54
hcfmusp.relation.referenceVasudev K, 2010, J CLIN PSYCHOPHARM, V30, P282, DOI 10.1097/JCP.0b013e3181db2684
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublicationa7b3531c-48ec-4ff4-93d2-772a94af0bbe
relation.isAuthorOfPublicationd133c36e-5929-47ed-875e-f6a229d517dd
relation.isAuthorOfPublication87bd8384-b428-475b-b25d-011a60f9d83c
relation.isAuthorOfPublication5d22f916-9e62-48bf-99aa-65b7cb87cb46
relation.isAuthorOfPublication.latestForDiscoverya7b3531c-48ec-4ff4-93d2-772a94af0bbe
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_DINIZ_Current_pharmacological_approaches_and_perspectives_in_the_treatment_2011.PDF
Tamanho:
137.55 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MPS
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/27